Actively Recruiting
Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient
Led by IBSA Farmaceutici Italia Srl · Updated on 2025-01-23
50
Participants Needed
1
Research Sites
93 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.
CONDITIONS
Official Title
Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Male or female
- Age 55 to 65 years inclusive
- In good general health based on medical history and current health
- Willing to maintain usual diet and exercise habits
- Able and willing to follow study requirements
You will not qualify if you...
- Body Mass Index less than 18.5 or 30 and above
- Difficulty swallowing (dysphagia)
- Known allergy or sensitivity to study ingredients
- Any significant medical condition or abnormal lab results making participation unsuitable
- Planned major surgery during study
- Unable or contraindicated to undergo study intervention
- Unable to follow study procedures due to language, psychological, or cognitive issues
- Use of new vitamins, herbal or dietary supplements, functional foods, or sports drinks aimed at enhancing performance within one month before and during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale Regionale di Lugano
Lugano, Switzerland
Actively Recruiting
Research Team
T
Tatiana Terrot
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here